Back to Trades
Karydas Daphne
DirectorCIK 0001816952
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 2
- Active
- 2025–2026
Karydas Daphne, Director, has filed 5 SEC reports (2025–2026), spread across 2 companies, totaling $1.7M in disclosed volume. Weighing $0 bought versus $925.5K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 17 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $85.7K |
| Jun 17 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $75.0K |
| May 29 | CMPS COMPASS Pathways plc | Karydas Daphne | Director | Award | $250.2K |
| Apr 2 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $75.0K |
| Nov 13 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $689.8K |
5 filings